which is better ozempic or tirzepatide vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, Semaglutide vs Tirzepatide, and Real Side Effects In adults with obesity but

This point is effectively made in a recently conducted large trial, which states that, our understanding of the mechanisms of cardiovascular protection with [the GLP-1 agonist] semaglutide remains speculativeclinical benefit is [thought to be] achieved through multiple interrelated pathways. Acknowledgement of this evidence gap prompted our lab, through use of a large animal model of CAD that replicates the features of disease as it occurs in humans, to investigate the cardiac consequences of semaglutide administration

Still, side effects can occur at any dosage, so it depends on each persons response to the medication, McGowan adds

What Does the Catalent Acquisition by Novo Holdings Mean for the Biopharma Industry

Hepatology 59 (5), 17381749